Vontobel Holding’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-30,000
Closed -$57.9K 1101
2023
Q1
$57.9K Buy
30,000
+16,000
+114% +$40.1K ﹤0.01% 1043
2022
Q4
$29.4K Hold
14,000
﹤0.01% 1071
2022
Q3
$32K Hold
14,000
﹤0.01% 1017
2022
Q2
$40K Hold
14,000
﹤0.01% 1005
2022
Q1
$64K Hold
14,000
﹤0.01% 1045
2021
Q4
$114K Sell
14,000
-83,213
-86% -$818K ﹤0.01% 1022
2021
Q3
$1.23M Sell
97,213
-2,082
-2% -$28.8K 0.01% 568
2021
Q2
$1.54M Buy
99,295
+12,079
+14% +$203K 0.01% 503
2021
Q1
$1.76M Buy
87,216
+416
+0.5% +$10.3K 0.01% 427
2020
Q4
$2.35M Buy
+86,800
New +$1.95M 0.02% 382

Other funds holding CLLS

Vontobel Holding's CLLS Position: Q2 2023 in Review

Vontobel Holding sold out of Cellectis (CLLS) in Q2 2023, closing a stake of 30,000 shares — an estimated $57.9K sold.

Vontobel Holding first reported a position in CLLS in Q4 2020 and held it in 10 quarters. The position peaked at $2.35M in Q4 2020. 36 funds tracked by Wall St. Rank hold CLLS as of Q2 2023.

  • Vontobel Holding reported no remaining Cellectis position as of Q2 2023 after selling out during the quarter.
  • Vontobel Holding sold 30,000 Cellectis shares in Q2 2023, an estimated $57.9K.
  • Vontobel Holding first reported a position in Cellectis in Q4 2020 and held it in 10 quarters.
  • Vontobel Holding's Cellectis position peaked at $2.35M in Q4 2020.
  • 36 funds tracked by Wall St. Rank held Cellectis as of Q2 2023.

Based on Vontobel Holding's 13F filing for Q2 2023, filed 24 Jul 2023.